243 related articles for article (PubMed ID: 12487927)
1. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue].
Tang L; Wang M; Ma J
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927
[TBL] [Abstract][Full Text] [Related]
2. [Relation between COX-2 protein expression and biologic behavior of ovarian carcinoma].
Tang LX; Wang M; Ma JW
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):261-3. PubMed ID: 12839690
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro].
Yin M; Shen H; Li TS; Li YP; Liu G
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):229-32. PubMed ID: 16647015
[TBL] [Abstract][Full Text] [Related]
4. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase 2 expression in serous tumors of the ovary.
Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in borderline ovarian tumors.
Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
[TBL] [Abstract][Full Text] [Related]
8. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway.
González E; Roselló-Catafau J; Jawerbaum A; Vela J; Sinner D; Pustovrh C; White V; Xaus C; Peralta C; Gimeno MA
Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):311-6. PubMed ID: 11427040
[TBL] [Abstract][Full Text] [Related]
9. Quantitative characterization of prostaglandins in the uterus of early pregnant cattle.
Ulbrich SE; Schulke K; Groebner AE; Reichenbach HD; Angioni C; Geisslinger G; Meyer HH
Reproduction; 2009 Aug; 138(2):371-82. PubMed ID: 19470711
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.
Uefuji K; Ichikura T; Mochizuki H
Clin Cancer Res; 2000 Jan; 6(1):135-8. PubMed ID: 10656441
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors.
Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R
Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318
[TBL] [Abstract][Full Text] [Related]
12. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
Giuliano F; Mitchell JA; Warner TD
J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys.
Warford-Woolgar L; Peng CY; Shuhyta J; Wakefield A; Sankaran D; Ogborn M; Aukema HM
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F897-904. PubMed ID: 16234308
[TBL] [Abstract][Full Text] [Related]
15. Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.
Peng CY; Sankaran D; Ogborn MR; Aukema HM
Exp Biol Med (Maywood); 2009 Jul; 234(7):737-43. PubMed ID: 19429858
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
Wang HX; Chen QK
Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.
Murata H; Kawano S; Tsuji S; Tsuji M; Sawaoka H; Kimura Y; Shiozaki H; Hori M
Am J Gastroenterol; 1999 Feb; 94(2):451-5. PubMed ID: 10022645
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
Wang KJ; Li H; Wei Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
